Home ›
Trademark Categories ›
Chemicals ›
2019 ›
EQ ›
EQUALASE
Trademark search for:
EQUALASE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-12-19 — Application filed
2019-12-23 — Application filed
2019-12-28 — Application filed
2020-01-15 — Assigned to examiner
2020-01-16 — Examiners amendment -written
2020-01-16 — Examiners amendment e-mailed
2020-01-16 — Notification of examiners amendment e-mailed
2020-01-16 — Examiner's amendment entered
2020-01-22 — Approved for pub - principal register
2020-01-27 — Assigned to lie
2020-01-27 — Assigned to lie
2020-02-12 — Notification of notice of publication e-mailed
2020-03-03 — Published for opposition
2020-03-03 — Official gazette publication confirmation e-mailed
2020-04-28 — Noa e-mailed - sou required from applicant
2020-10-28 — Sou extension 1 filed
2020-11-12 — Sou extension received with teas petition
2020-11-12 — Notice of revival - e-mailed
2020-11-12 — Petition to revive-granted
2020-11-12 — Teas petition to revive received
2021-02-09 — Case assigned to intent to use paralegal
2021-02-10 — Sou extension 1 granted
2021-02-11 — Notice of approval of extension request e-mailed
2021-05-31 — Application abandoned
2021-05-31 — Final status recorded
2021-06-01 — Application abandoned
Owner Information
Zymo Research Corp.
Aliso Viejo , CA
Zymo Research Corp.
Irvine , CA
Correspondent
Jonathan A Claypool ZYMO RESEARCH CORP. 17062 MURPHY AVENUE IRVINE, CA 92614 UNITED STATES
Filing Details
Filing Date:
2019-12-19
Status Date:
2021-05-31
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.